The Effect of Breathing Exercise on Chemotherapy-induced Nausea and Vomiting in With Autologous Hematopoietic Stem Cell Transplantation Patients
Chemotherapy-induced Nausea and Vomiting
About this trial
This is an interventional prevention trial for Chemotherapy-induced Nausea and Vomiting focused on measuring Nausea, Vomiting, Breathing exercise, Autologous Hematopoietic Stem Cell Transplantation, Chemotherapy
Eligibility Criteria
Inclusion Criteria:
- Least 18-years-old,
- Autologous hematopoietic stem cell transplantation and take high-dose chemotherapy,
- not have any communicative problems,
- not have Coronavirus disease (COVID-19) disease or respiratory disease,
- Hb value of 10 and above and
- knowing how to read, write, and speak Turkish
Exclusion Criteria:
- have respiratory disease and Coronavirus disease (COVID-19),
- having any communication and psychiatric problem,
- not knowing how to read, write, and speak Turkish,
- not wanting to participate in the study and have anemia.
Sites / Locations
- Koç University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Other
Breathing exercise group
Control group
The researcher will collect the data using Patient Information Form, Rhodes Index of Nausea, Vomiting and Retching Scale, Patient Diary for determining the number of nausea, vomiting, and retching episodes and the hours of breathing exercise of the patient, and Daily Nutritional Consumption Amount Form through face-to-face interview technique on the first day and for 14 days. During chemotherapy and stem cell transplantation, antiemetic treatment included in the treatment protocol will be applied to the patients. The patients will train about the application of breathing exercise by the researcher. They will be asked to do this breathing exercise with the guideline for at least 5 min in case of sensation of nausea and vomiting for 14 days.
The researcher will collect the data using Patient Information Form, Rhodes Index of Nausea, Vomiting and Retching Scale, Patient Diary for determining the number of nausea, vomiting, and retching episodes and the hours of breathing exercise of the patient, and Daily Nutritional Consumption Amount Form through face-to-face interview technique on the first day. The researcher will continue to fill out Rhodes Index of Nausea, Vomiting and Retching Scale, Patient Diary for determining the number of nausea, vomiting, and retching episodes and the hours of breathing exercise of the patient, and Daily Nutritional Consumption Amount Form for 14 days. During chemotherapy and stem cell transplantation, antiemetic treatment included in the treatment protocol will be applied to the patients.